The study, published online in Cell Stem Cell , demonstrates the potential of utilizing iPS cells to develop cell types that could offer treatment for a wide range of conditions, including diabetes, liver and lung diseases, without the barrier of immune rejection.
http://www.sciencedaily.com/releases/2013/01/130125154813.htm
http://www.sciencedaily.com/releases/2013/01/130125154813.htm
No comments:
Post a Comment